| Filed | Form | Description | |
|---|---|---|---|
| 8/8/24 | DEFA14A | DEFA14A | → |
| 8/8/24 | DEF 14A | DEF 14A | → |
| 7/29/24 | PRE 14A | PRE 14A | → |
| 4/20/23 | DEFA14A | DEFA14A | → |
| 4/20/23 | DEF 14A | DEF 14A | → |
| 4/22/22 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 1/10/25 | 3 | OWNERSHIP DOCUMENT | → |
| 8/19/24 | SC 13D/A | SC 13D/A | → |
| 6/16/23 | 4 | OWNERSHIP DOCUMENT | → |
| 6/21/22 | 3 | FORM 3 | → |
| 8/17/21 | 4 | OWNERSHIP DOCUMENT | → |
| 11/18/20 | 4 | OWNERSHIP DOCUMENT | → |
| ↓ | |||
Enzon Pharmaceuticals, Inc. is a pharmaceutical company.